JPWO2025170079A5 - - Google Patents

Info

Publication number
JPWO2025170079A5
JPWO2025170079A5 JP2025540402A JP2025540402A JPWO2025170079A5 JP WO2025170079 A5 JPWO2025170079 A5 JP WO2025170079A5 JP 2025540402 A JP2025540402 A JP 2025540402A JP 2025540402 A JP2025540402 A JP 2025540402A JP WO2025170079 A5 JPWO2025170079 A5 JP WO2025170079A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cells
cell lysate
derived
chronic inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025540402A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2025170079A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2025/004430 external-priority patent/WO2025170079A1/ja
Publication of JPWO2025170079A1 publication Critical patent/JPWO2025170079A1/ja
Publication of JPWO2025170079A5 publication Critical patent/JPWO2025170079A5/ja
Pending legal-status Critical Current

Links

JP2025540402A 2024-02-09 2025-02-10 Pending JPWO2025170079A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2024018774 2024-02-09
PCT/JP2025/004430 WO2025170079A1 (ja) 2024-02-09 2025-02-10 慢性炎症を抑制するための医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2025170079A1 JPWO2025170079A1 (https=) 2025-08-14
JPWO2025170079A5 true JPWO2025170079A5 (https=) 2026-01-15

Family

ID=96700007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025540402A Pending JPWO2025170079A1 (https=) 2024-02-09 2025-02-10

Country Status (2)

Country Link
JP (1) JPWO2025170079A1 (https=)
WO (1) WO2025170079A1 (https=)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102503695B1 (ko) * 2013-02-28 2023-02-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 줄기세포를 동원하기 위한 방법 및 조성물
CA3025285A1 (en) * 2016-05-25 2017-11-30 Erasmus University Medical Center Rotterdam Use of mesenchymal stem cells and parts thereof
KR20190003316A (ko) * 2017-06-30 2019-01-09 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부염 개선 용도
WO2019073999A1 (ja) * 2017-10-13 2019-04-18 マイクロニクス株式会社 細胞内液精製システム、細胞内液精製方法、炎症性腸疾患の予防剤、改善剤または治療剤、あるいは、精子活性化剤、もしくは、化粧品成分を製造する製造方法、炎症性腸疾患の予防剤、改善剤または治療剤、および、精子活性化剤の製造方法
EP3818158B1 (en) * 2018-07-02 2025-10-08 Shi-Lung Lin In-vitro induction of adult stem cell expansion and derivation
US12023356B2 (en) * 2018-07-04 2024-07-02 Masanori Saeki Stem cell filtrate preparation and method for preparing same
JP7525840B2 (ja) * 2020-01-27 2024-07-31 国立大学法人旭川医科大学 下部尿路機能障害の治療
KR102193175B1 (ko) * 2020-04-07 2020-12-18 주식회사 엑소스템텍 통증조절인자를 함유한 줄기세포유래 엑소좀 및 그 용도
EP3936616A1 (en) * 2020-07-10 2022-01-12 Charité - Universitätsmedizin Berlin Microrna-targeted therapy for cardiac repair
JP6894652B1 (ja) * 2020-09-08 2021-06-30 デクソンファーマシューティカルズ株式会社 組織修復剤、組織修復剤の使用方法およびスクリーニング方法
WO2022180661A1 (ja) * 2021-02-24 2022-09-01 株式会社Meis Technology 変形性関節症又は靭帯若しくは腱の治療製剤、及びその製造方法。
JP7492757B2 (ja) * 2022-03-22 2024-05-30 Dexonファーマシューティカルズ株式会社 遺伝子の発現制御剤、アルツハイマー病の予防薬または治療薬および認知症の改善方法
JP2023144863A (ja) * 2022-03-28 2023-10-11 Dexonファーマシューティカルズ株式会社 微小粒子、パーキンソン病の予防薬または治療薬およびパーキンソン病の改善方法
JP2023155686A (ja) * 2022-04-11 2023-10-23 Dexonファーマシューティカルズ株式会社 微小粒子、血管新生眼疾患の予防薬または治療薬および血管新生眼疾患の改善方法
JP2024000504A (ja) * 2022-06-20 2024-01-05 Dexonファーマシューティカルズ株式会社 Hmgb1の発現制御剤;急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法

Similar Documents

Publication Publication Date Title
Chapman et al. Janus kinase inhibitors in dermatology: Part I. A comprehensive review
JPWO2025170079A5 (https=)
Wunner Rabies virus
Takizawa et al. Chromatin structure meets cryo-EM: dynamic building blocks of the functional architecture
JP2023164892A5 (https=)
JP2010053122A5 (https=)
CN119203611B (zh) 一种非对称拱桥非线性跃越屈曲临界荷载近似解析方法
Zhai et al. Novel stability criteria of generalized neural networks with time-varying delay based on the same augmented LKF and bounding technique
US7588788B2 (en) Immune modulation and anti-allergy activities of Zingiber zerumbet
AR073800A1 (es) Tratamiento de la infeccion del virus de la hepatitis c con sobreexpresion de micro rna -196
Ligade et al. Research output of India compared to BRICS countries in publishing pharmacology, toxicology and pharmaceutics research papers.
CN102108883B (zh) 半转速核电汽轮机末级动叶片
CN104595238B (zh) 水力性能优异的系列斜式进水流道及其应用方法
BR112023000839A2 (pt) Anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos para produzir um anticorpo que se liga a notch2 humano, para tratar um indivíduo com uma doença pulmonar muco-obstrutiva e para reduzir o número de células secretoras em um indivíduo, composição farmacêutica, anticorpo, anticorpo para uso e uso do anticorpo
ZHAO A mean particle swarm optimization algorithm based on adaptive inertia weight
Elnaggar et al. Recent trends in the delivery of RNA drugs: Beyond the liver, more than vaccine
CN211372387U (zh) 新型低氮cfb锅炉结构
CN104595918A (zh) 一种带有流线型导流模块的烟道弯头
Hu et al. The Improved Design Techniques of Comparator Performance
Wenya Optimization of Spatial Structure of Tourist Attractions in Binzhou City under the Background of Regional Tourism.
JPWO2022181660A5 (https=)
Shhatha Simulating large scale structural members by using Buckingham theorem: Case study
Hu et al. From ketogenic metabolism to targeted therapeutics: current advances in β-hydroxybutyrylation
Firdaus et al. Rekonseptualisasi Nusyuz dan Syiqaq di Era Digital: Analisis Problematika dan Mekanisme Penyelesaian Modern: Penelitian
CN205503340U (zh) 短弦长活动导叶